Literature DB >> 16585309

Screening for biliary atresia by infant stool color card in Taiwan.

Shan-Ming Chen1, Mei-Hwei Chang, Jung-Chieh Du, Chieh-Chung Lin, An-Chyi Chen, Hung-Chang Lee, Beng-Huat Lau, Yao-Jong Yang, Tzee-Chung Wu, Chia-Hsiang Chu, Ming-Wei Lai, Huey-Ling Chen.   

Abstract

OBJECTIVE: We aimed to detect biliary atresia (BA) in early infancy to prevent additional liver damage because of the delay of referral and surgical treatment and to investigate the incidence rate of BA in Taiwan.
METHODS: A pilot study to screen the stool color in infants for the early diagnosis of BA was undertaken from March 2002 to December 2003. We had designed an "infant stool color card" with 7 numbers of different color pictures and attached it to the child health booklet. Parents were then asked to observe their infant's stool color by using this card. The medical staff would check the number that the parents chose according to their infant's stool color at 1 month of age during the health checkup and then send the card back to the stool color card registry center.
RESULTS: The average return rate was approximately 65.2% (78,184 infants). A total of 29 infants were diagnosed as having BA, and 26 were screened out by stool color card before 60 days of age. The sensitivity, specificity, and positive predictive value were 89.7%, 99.9%, and 28.6%, respectively. Seventeen (58.6%) infants with BA received a Kasai operation within 60-day age period. The estimated incidence of BA in screened newborns was 3.7 of 10,000.
CONCLUSIONS: The stool color card was a simple, efficient, and applicable mass screening method for early diagnosis and management of BA. The program can also help in estimating the incidence and creating a registry of these patients.

Entities:  

Mesh:

Year:  2006        PMID: 16585309     DOI: 10.1542/peds.2005-1267

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  33 in total

1.  Reduction of the ages at diagnosis and operation of biliary atresia in Taiwan: A 15-year population-based cohort study.

Authors:  Jen-Shyang Lin; Solomon Chih-Cheng Chen; Chin-Li Lu; Hung-Chang Lee; Chun-Yan Yeung; Wai-Tao Chan
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

2.  Newborn Screening for Biliary Atresia.

Authors:  Kasper S Wang
Journal:  Pediatrics       Date:  2015-12       Impact factor: 7.124

3.  Clinical practices among healthcare professionals concerning neonatal jaundice and pale stools.

Authors:  Ermelinda Santos Silva; Helena Moreira Silva; Lia Azevedo Lijnzaat; Cláudia Melo; Elísio Costa; Esmeralda Martins; Ana Isabel Lopes
Journal:  Eur J Pediatr       Date:  2017-01-12       Impact factor: 3.183

4.  Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia.

Authors:  Barrett H Barnes; Rebecca M Tucker; Fabian Wehrmann; Doug G Mack; Yoshiyuki Ueno; Cara L Mack
Journal:  Liver Int       Date:  2008-11-15       Impact factor: 5.828

5.  Swiss outcomes in biliary atresia: are there lessons to be learned?

Authors:  Ronald J Sokol
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-03       Impact factor: 2.839

6.  An iPhone application using a novel stool color detection algorithm for biliary atresia screening.

Authors:  Eri Hoshino; Kuniyoshi Hayashi; Mitsuyoshi Suzuki; Masayuki Obatake; Kevin Y Urayama; Satoshi Nakano; Yasuyuki Taura; Masaki Nio; Osamu Takahashi
Journal:  Pediatr Surg Int       Date:  2017-08-17       Impact factor: 1.827

7.  Patients with biliary atresia have elevated direct/conjugated bilirubin levels shortly after birth.

Authors:  Sanjiv Harpavat; Milton J Finegold; Saul J Karpen
Journal:  Pediatrics       Date:  2011-11-21       Impact factor: 7.124

Review 8.  Current management of biliary atresia.

Authors:  Deirdre A Kelly; Mark Davenport
Journal:  Arch Dis Child       Date:  2007-09-18       Impact factor: 3.791

Review 9.  Early diagnosis of neonatal cholestatic jaundice: test at 2 weeks.

Authors:  Eric I Benchimol; Catharine M Walsh; Simon C Ling
Journal:  Can Fam Physician       Date:  2009-12       Impact factor: 3.275

Review 10.  Biliary atresia.

Authors:  Giorgina Mieli-Vergani; Diego Vergani
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.